LGALS3BP and idiopathic pulmonary arterial hypertension: Our proteomic analysis revealed significant up‐regulation of LGALS3BP in IPAH patients compared with healthy controls (FC = 1.36, p < 0.001), with subsequent ELISA validation confirming this finding, which provides a theoretical foundation for understanding the pathophysiological relevance of LGALS3BP in IPAH.